These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30380309)

  • 1. The four-dimensional Kirschner-Panetta type cancer model: How to obtain tumor eradication?
    Krishchenko AP; Starkov KE
    Math Biosci Eng; 2018 Oct; 15(5):1243-1254. PubMed ID: 30380309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of the tumor-immune-virus interactions: Convergence conditions to tumor-only or tumor-free equilibrium points.
    Starkov KE; Garfias GA
    Math Biosci Eng; 2018 Dec; 16(1):421-437. PubMed ID: 30674126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Clearance Analysis on a Cancer Chemo-Immunotherapy Mathematical Model.
    Valle PA; Coria LN; Salazar Y
    Bull Math Biol; 2019 Oct; 81(10):4144-4173. PubMed ID: 31264136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy.
    Starkov KE; Bunimovich-Mendrazitsky S
    Math Biosci Eng; 2016 Oct; 13(5):1059-1075. PubMed ID: 27775397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics aspects and bifurcations of a tumor-immune system interaction under stationary immunotherapy.
    Torres-Espino G; Vidal C
    Math Biosci; 2024 Mar; 369():109145. PubMed ID: 38232943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the global dynamics of a model for tumor immunotherapy.
    Kirschner D; Tsygvintsev A
    Math Biosci Eng; 2009 Jul; 6(3):573-83. PubMed ID: 19566127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour suppression by immune system through stochastic oscillations.
    Caravagna G; d'Onofrio A; Milazzo P; Barbuti R
    J Theor Biol; 2010 Aug; 265(3):336-45. PubMed ID: 20580640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T model of growth and its application in systems of tumor-immune dynamics.
    Tabatabai MA; Eby WM; Singh KP; Bae S
    Math Biosci Eng; 2013 Jun; 10(3):925-38. PubMed ID: 23906156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-tuning anti-tumor immunotherapies via stochastic simulations.
    Caravagna G; Barbuti R; d'Onofrio A
    BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S8. PubMed ID: 22536975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A switching control law approach for cancer immunotherapy of an evolutionary tumor growth model.
    Doban AI; Lazar M
    Math Biosci; 2017 Feb; 284():40-50. PubMed ID: 27665680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaos synchronization and Nelder-Mead search for parameter estimation in nonlinear pharmacological systems: Estimating tumor antigenicity in a model of immunotherapy.
    Pillai N; Craig M; Dokoumetzidis A; Schwartz SL; Bies R; Freedman I
    Prog Biophys Mol Biol; 2018 Nov; 139():23-30. PubMed ID: 29928905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the optimal therapeutic protocols in cancer immunotherapy.
    Cappuccio A; Castiglione F; Piccoli B
    Math Biosci; 2007 Sep; 209(1):1-13. PubMed ID: 17416392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol.
    Qomlaqi M; Bahrami F; Ajami M; Hajati J
    Math Biosci; 2017 Oct; 292():1-9. PubMed ID: 28713023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.
    de Pillis LG; Gu W; Radunskaya AE
    J Theor Biol; 2006 Feb; 238(4):841-62. PubMed ID: 16153659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy.
    Kiran KL; Lakshminarayanan S
    Biosystems; 2010 Aug; 101(2):117-26. PubMed ID: 20639123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth.
    Ledzewicz U; Olumoye O; Schättler H
    Math Biosci Eng; 2013 Jun; 10(3):787-802. PubMed ID: 23906150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
    Maccalli C; Parmiani G; Ferrone S
    Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mathematical model of tumor-immune interactions.
    Robertson-Tessi M; El-Kareh A; Goriely A
    J Theor Biol; 2012 Feb; 294():56-73. PubMed ID: 22051568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dynamical model of tumour immunotherapy.
    Frascoli F; Kim PS; Hughes BD; Landman KA
    Math Biosci; 2014 Jul; 253():50-62. PubMed ID: 24759513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-stability and multi-instability phenomena in a mathematical model of tumor-immune-virus interactions.
    Eftimie R; Dushoff J; Bridle BW; Bramson JL; Earn DJ
    Bull Math Biol; 2011 Dec; 73(12):2932-61. PubMed ID: 21476110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.